Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Abiraterone Acetate × Clear all

Sponsor

Conditions

Prostatic Neoplasms 62 Neoplasm Metastasis 6 Prostatic Neoplasms, Castration-Resistant 4 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Prostate Cancer Metastatic 2 Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Hyperaldosteronism 1 Castration-resistant Prostate Cancer 1 Adenocarcinoma 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡